Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01842633Phase 3Terminated
A Phase 3 trial of paracetamol + caffeine in episodic tension-type headache (ETTH), sponsored by GSK. Started Apr 2013; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01842633.